共 50 条
- [31] New evidence for the role of interferon regulatory factor 5 in the development of systemic lupus erythematosus: comment on the article by Tada et al Reply ARTHRITIS AND RHEUMATISM, 2011, 63 (08): : 2544 - 2544
- [32] Epidemiology of systemic lupus erythematosus in the United Kingdom: Comment on the article by Somers et al ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (02): : 297 - 297
- [33] APRIL in systemic lupus erythematosus: Essential or dispensable? Comment on the article by Jacob et al ARTHRITIS AND RHEUMATISM, 2012, 64 (06): : 2052 - 2053
- [34] Estimates of the US prevalence of systemic lupus erythematosus: comment on the article by Lawrence et al ARTHRITIS AND RHEUMATISM, 1999, 42 (02): : 396 - 396
- [35] Characterization of flares in patients with systemic lupus erythematosus: comment on the article by Ho et al ARTHRITIS AND RHEUMATISM, 2003, 48 (02): : 581 - 582
- [36] Apolipoprotein(a) deposition in atherosclerotic coronary arteries of a patient with systemic lupus erythematosus: comment on the article by Romero et al - Reply ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : 2142 - 2142
- [37] Increased levels of interleukin-18 in patients with systemic lupus erythematosus: comment on the article by Shibatomi et al - Reply ARTHRITIS AND RHEUMATISM, 2002, 46 (05): : 1411 - 1412
- [40] Epigenetic considerations in investigating the cause of systemic lupus erythematosus: comment on the article by Chagnon et al ARTHRITIS AND RHEUMATISM, 2007, 56 (03): : 1035 - 1035